Inventor · disambiguated record
Brian Cochran
Also filed as: COCHRAN BRIAN · COCHRAN BRIAN M · COCHRAN BRIAN MCNEIL
8 granted patents·9 pending applications·85 citations·filing 1997–2025
85Inventor score
Top patents by PatentIndex Score
17 records- 0195US11299491B2Synthesis of key intermediate of KRAS G12C inhibitor compoundAMGEN INC·Filed 2019·Granted Apr 12, 2022·20 cites·1 claims
- 0290US9376386B2Processes of making and crystalline forms of a MDM2 inhibitorAMGEN INC·Filed 2014·Granted Jun 28, 2016·7 cites·48 claims
- 0387US2025368642A1Synthesis of key intermediate of kras g12c inhibitor compoundAMGEN INC·Filed 2025·Application pending·0 cites
- 0487US2025368643A1Synthesis of key intermediate of kras g12c inhibitor compoundAMGEN INC·Filed 2025·Application pending·0 cites
- 0586US12391691B2Synthesis of key intermediate of KRAS G12C inhibitor compoundAMGEN INC·Filed 2024·Granted Aug 19, 2025·0 cites·14 claims
- 0685US9801867B2Processes of making and crystalline forms of a MDM2 inhibitorAMGEN INC·Filed 2016·Granted Oct 31, 2017·2 cites·30 claims
- 0784US2023301974A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2023·Application pending·0 cites
- 0878US5953859ARechargeable live planter assembly and method of use thereofINSTA BED FLORAL SYSTEMS·Filed 1997·Granted Sep 21, 1999·55 cites·4 claims
- 0977US9855259B2Processes of making and crystalline forms of a MDM2 inhibitorAMGEN INC·Filed 2016·Granted Jan 2, 2018·1 cites·14 claims
- 1076US12391689B2Synthesis of key intermediate of KRAS G12C inhibitor compoundAMGEN INC·Filed 2022·Granted Aug 19, 2025·0 cites·13 claims
- 1175US2022280496A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2021·Application pending·0 cites
- 1274US2020281912A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2019·Application pending·0 cites
- 1370US2018092898A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2017·Application pending·0 cites
- 1468US2025295647A1Processes of making and crystalline forms of a mdm2 inhibitorAMGEN INC·Filed 2024·Application pending·0 cites
- 1552US2022363680A1Processes for the synthesis of valbenazineNEUROCRINE BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1650US2023065034A1Crf receptor antagonists and methods of useNEUROCRINE BIOSCIENCES INC·Filed 2020·Application pending·0 cites
- 1744US12486250B2Muscarinic receptor 4 antagonists and methods of useNEUROCRINE BIOSCIENCES INC·Filed 2020·Granted Dec 2, 2025·0 cites·2 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →